Etomidate as a rectal induction agent. Part I. A preliminary study in rats

Area of Science:

• Veterinary Anesthesiology
• Pharmacology
• Rodent Models in Research

Background:

• Etomidate is a widely used anesthetic agent.
• Rectal administration offers a potential alternative route for drug delivery.
• Investigating novel anesthetic delivery methods is crucial for animal research and clinical applications.

Purpose of the Study:

• To evaluate the efficacy, safety, and dose-response of rectally administered etomidate in rats.
• To determine the onset, duration, and recovery parameters of rectal etomidate anesthesia.
• To assess the local tissue effects of rectal etomidate administration.

Main Methods:

• Male Long-Evans rats (n=50) received rectal etomidate (1.25% in sterile water) at doses from 4-12 mg/kg.
• Onset and duration of ataxia and hypnosis (loss of righting ability) were recorded.
• Histological examination of rectal and colonic mucosa was performed.

Main Results:

• Ataxia occurred in all rats; hypnosis was observed at doses ≥6 mg/kg.
• Doses ≥8 mg/kg induced hypnosis within an average of 3.3 minutes, with recovery in 10.4 minutes.
• 1.25% etomidate caused no significant mucosal changes, while undiluted 12.5% caused necrosis.

Conclusions:

• Rectal etomidate (1.25% in sterile water) is an effective, predictable, and safe anesthetic in rats.
• The rectal hypnotic dose is approximately ten times the intravenous dose.
• Further investigation for pediatric clinical anesthesia is warranted.